Pitcairn Co. lowered its position in shares of Humana Inc. (NYSE:HUM) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 2,504 shares of the insurance provider’s stock after selling 12 shares during the period. Pitcairn Co.’s holdings in Humana were worth $450,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of the stock. Renaissance Technologies LLC boosted its position in Humana by 246.3% in the first quarter. Renaissance Technologies LLC now owns 446,000 shares of the insurance provider’s stock valued at $81,596,000 after buying an additional 317,200 shares during the last quarter. Adage Capital Partners GP L.L.C. boosted its position in Humana by 39.4% in the first quarter. Adage Capital Partners GP L.L.C. now owns 940,360 shares of the insurance provider’s stock valued at $172,039,000 after buying an additional 265,700 shares during the last quarter. Orbis Allan Gray Ltd purchased a new position in Humana during the first quarter valued at $38,209,000. Loomis Sayles & Co. L P boosted its position in Humana by 52.6% in the first quarter. Loomis Sayles & Co. L P now owns 300,004 shares of the insurance provider’s stock valued at $54,886,000 after buying an additional 103,370 shares during the last quarter. Finally, Bank of Montreal Can purchased a new position in Humana during the second quarter valued at $14,049,000. 93.24% of the stock is currently owned by institutional investors and hedge funds.
Humana Inc. (NYSE:HUM) traded down 0.25% during mid-day trading on Friday, hitting $175.55. 502,480 shares of the stock were exchanged. The firm has a market capitalization of $26.17 billion, a price-to-earnings ratio of 26.97 and a beta of 0.91. Humana Inc. has a 52 week low of $150.00 and a 52 week high of $191.65. The company’s 50-day moving average price is $177.47 and its 200 day moving average price is $176.60.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $0.07. The company had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. Humana’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.67 EPS. Equities research analysts expect that Humana Inc. will post $9.26 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a yield of 0.66%. Humana’s dividend payout ratio is currently 18.18%.
HUM has been the topic of several research analyst reports. Jefferies Group raised shares of Humana from a “hold” rating to a “buy” rating and upped their price target for the stock from $158.89 to $210.00 in a report on Monday, July 18th. JPMorgan Chase & Co. cut shares of Humana from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $196.00 to $150.00 in a report on Friday, July 8th. Argus reiterated a “hold” rating on shares of Humana in a research report on Tuesday, August 23rd. Wolfe Research started coverage on shares of Humana in a research report on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 target price for the company. Finally, Credit Suisse Group AG upped their target price on shares of Humana from $175.00 to $188.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 16th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Humana currently has an average rating of “Buy” and a consensus target price of $200.93.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.